JAKARTA: Kalbe Farma prepares IDR5 trillion to acquire some nutrition and consumer health companies in Indonesia or overseas.
Investors Relations of Kalbe Farma Joyce V.Handajani said the company now has strong internal cash of IDR2.1 trillion which can be used to support inorganic growth. Besides the company also has treasury stock of 780.99 million or 7.7% from the floating stocks worth IDR2.81 trillion.
“Kalbe is now prioritizing inorganic growth. The existing cash can be used for merger and acquisition [M&A], treasury stock can be sold to support M&A,” she said yesterday.
According to her, now the company is still conducting due diligence on several local and foreign companies. However, he refused to reveal the number of the health company which will be acquired. (T03/aph)